In experimental models of chronic pancreatitis [68], renal fibrosis [69], and pulmonary fibrosis [70], BMP2 has been reported to have anti-fibrotic properties, mainly related to inhibition of TGF-β-related pathways. This evidence concerns the gene TGFB1 and renal fibrosis.